MassMutual Private Wealth & Trust’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
BGI
MassMutual Private Wealth & Trust's ADMA Position: Q3 2026 in Review
MassMutual Private Wealth & Trust increased its ADMA Biologics (ADMA) stake by 87% in Q3 2026, buying an estimated $1.45K and bringing the position to 338 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.
MassMutual Private Wealth & Trust first reported a position in ADMA in Q1 2024 and has held it in 11 quarters since. The position peaked at $7.06K in Q2 2025. 272 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.
- MassMutual Private Wealth & Trust held 338 shares of ADMA Biologics worth $3.39K as of Q3 2026.
- MassMutual Private Wealth & Trust bought 157 ADMA Biologics shares in Q3 2026, an estimated $1.45K.
- ADMA Biologics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1763 holding.
- MassMutual Private Wealth & Trust first reported a position in ADMA Biologics in Q1 2024 and has held it in 11 quarters since.
- MassMutual Private Wealth & Trust's ADMA Biologics position peaked at $7.06K in Q2 2025.
- 272 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.
Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.